The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling studyCamille Maringe, Ajay Aggarwal|The Lancet Oncology|2020Cited by 1.9k
An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income CountriesJ. Connor Wells, Christopher M. Booth, Shubham Sharma et al.|JAMA Oncology|2021Cited by 165
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology CommissionMark Lawler, Richard Sullivan, Lynne Davies et al.|The Lancet Oncology|2022Cited by 104
Common Sense Oncology: outcomes that matterChristopher M. Booth, Bishal Gyawali, Brooke E. Wilson et al.|The Lancet Oncology|2023Cited by 101
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P. Lythgoe, Richard Sullivan, Jonathan Krell et al.|The Lancet Oncology|2023Cited by 20